What is the Innovative Medicines Initiative (IMI)?
The Innovative Medicines Initiative (IMI) is a public-private partnership between the European Union and the European pharmaceutical industry, represented by the European Federation of Pharmaceutical Industries and Associations (EFPIA). Its main goal is to improve the development of new medicines by fostering collaboration between key stakeholders such as academia, industry, small and medium-sized enterprises (SMEs), patient organizations, and regulatory authorities.